M1231 in Participants With Solid Tumors

NCT04695847 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Solid Tumors
Esophageal Cancer
Non-Small Cell Lung Cancer

Interventions

DRUG: M1231
DRUG: M1231

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators

[object Object]